Previous close | 13.46 |
Open | 12.20 |
Bid | 12.05 |
Ask | 14.10 |
Strike | 57.50 |
Expiry date | 2024-05-17 |
Day's range | 12.20 - 13.46 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Bristol-Myers Squibb ( NYSE:BMY ) First Quarter 2024 Results Key Financial Results Revenue: US$11.9b (up 4.7% from 1Q...
Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.
PRINCETON, N.J., April 26, 2024--CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine....